Company: REVB
Filing Date: 2025-06-25
Form Type: 8-K
Source: 0000950170-25-089972
Chunk: 1

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-06-25
Form: 8-K
Item: Item 5.07
Chunk 1
---
,548          2,681          253,797      494,049  

There were no broker non-votes regarding this proposal.

Proposal 5 - Approval of Reverse Stock Splits

Stockholders approved a proposal to grant discretionary authority to the board of directors to effect one or more reverse stock splits of our common stock within one (1) year of June 23, 2025, at a specific ratio of one-for-two to a maximum of one-for-250, with the specific ratio(s) to be fixed within this range by the board of directors in its sole discretion without further stockholder approval, based on the votes below:

      For      Against      Abstain  
 ─────────────────────────────────────
  729,206       66,503          366  

There were no broker non-votes regarding this proposal.

Proposal 6 - Approval of Issuance of Common Stock in Excess of Exchange Cap

Stockholders approved the reservation and issuance of shares of our common stock pursuant to the Class H Warrants, dated May 29, 2025, entered into between us and certain purchasers in connection with a stock purchase agreement dated the same date, to the extent that issuances under the Class H Warrants may exceed 20% of the Company’s total outstanding shares, which could trigger the Exchange Cap, based on the votes listed below:

      For      Against      Abstain  
 ─────────────────────────────────────
  755,720       37,572        2,783  

There were no broker non-votes regarding this proposal.

Proposal 7 - Approval of Change of Corporate Domicile

The proposal to change the Company's domicile from Delaware to Nevada, notwithstanding more than 89% of stockholders present voted in favor of the proposal, did not receive the required number of affirmative votes from the outstanding shares to pass at this time, based on the votes listed below:

      For      Against      Abstain  
 ─────────────────────────────────────
  268,216       30,800      467,059  

There were no broker non-votes regarding this proposal.

Proposal 8 - Ratification of the Auditor

Stockholders ratified Baker Tilly US, LLP to audit our financial statements for the fiscal year ending December 31, 2025, based on the votes listed below:

      For      Against      Abstain  
 ─────────────────────────────────────
  276,337       20,913      498,